MCCLUNG DAVID (Chief Financial Officer) purchased 43.7% of their position (13.12K shares) of BIOCARDIA, INC. on the open market
Open‑market purchase worth $25.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/25/2025ACC: 0001437749-25-013200
Officer· Chief Financial Officer
Since Sep 2018
+26.25K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
26.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.12K
Price / share
$1.91
Trade value
$25K
% of position
43.7%
4/23/2025
30.01K→43.13K
Total
Net shares
+13.12K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2025 | P · Purchase | +13.12K | $1.91 | $25K | 43.7% | 30.01K | 43.13K |
| Total | +13.12K | $25K | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
13.12K shares
Shares
+13.12K
Strike price
1.9050
Held after
21.46K
Exercisable
—
4/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock13.12K shares | 4/23/2025 | P · Purchase | +13.12K | 1.9050 | — | 21.46K |